Nombre del producto |
nimodipine |
Nombre en inglés |
nimodipine; 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester; isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; 2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3-(2-methoxyethyl) 5-(1-methylethyl) (4S)-2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate; 3-(2-methoxyethyl) 5-(1-methylethyl) (4R)-2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate |
Fórmula molecular |
C21H26N2O7 |
Peso Molecular |
418.4403 |
InChI |
InChI=1/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,17,19H,9-10H2,1-5H3/t17?,19-/m0/s1 |
Número de registro CAS |
66085-59-4 |
EINECS |
266-127-0 |
Estructura Molecular |
|
Densidad |
1.25g/cm3 |
Punto de fusión |
125℃ |
Punto de ebullición |
526.3°C at 760 mmHg |
Índice de refracción |
1.561 |
Punto de inflamación |
272.1°C |
Presión de vapor |
3.63E-11mmHg at 25°C |
Símbolos de Peligro |
Xn:Harmful;
|
Códigos de Riesgos |
R20/21/22:;
|
Descripción de Seguridad |
S36:;
|
|